We'd developed an RSS feed of Bloomberg and AP clips pertinent to pharma, but let it slide a bit, due to technical issues and the fact that Bloomberg et al. didn't cover the drug industry (at least on TV) as much as they generally do, in May.
However, it's back in business now, and you'll find a number of potentially interesting shorts (click here to access the entire feed):
An interview with Zymogenic's CEO. (Bayer has just signed a $200+-million deal with them for a new blood clotting agent)
A report on Amgen by Montgomery and Lazzard analysts
An update on Gilead's new treatment for lung disease
An overview of the cancer and cardiovascular drug pipeline by Mark Monane of Needham
A look at weight loss drugs, in light of recent developments with Acomplia/Zimulti, with Citi analyst
An interview with Puerto Rico's governor about biotech
AMS
